Real Estate
Filter News
Found 7,153 articles
-
The new R&D facility is a product of its new licensing deal with BridgeBio Pharma and will operate under Helsinn Therapeutics.
-
Grand Opening of Kodiak Sciences' Purpose-built Bioconjugation Facility to Support Potential Commercial Manufacture of KSI-301, an Antibody Biopolymer Conjugate for Retinal Diseases
5/19/2022
Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, and Lonza announced today the opening of a new, custom-built, bioconjugation facility within Lonza's Ibex® Dedicate manufacturing complex in Visp (CH).
-
Vertex Pharmaceuticals dedicated a new site in Boston’s Seaport. But the company seemed to say, “But wait! There’s more!” and announced it plans to build another facility in the area.
-
Nuritas™ Announces North American Headquarters, CEO to Relocate to US
5/17/2022
Nuritas, a biotechnology company using AI to revolutionize the discovery of untapped, natural, bioactive peptides, announced it will build its North American headquarters in Connecticut, near Yale University.
-
Quotient Limited Announces Opening of Office in Dubai, United Arab Emirates
5/17/2022
Quotient Limited announced the opening of its new office in Dubai, UAE, and the incorporation of its subsidiary Quotient Middle-East and Africa FZ LLC, as part of its ongoing expansion plans to better support customers in the region.
-
Kriya Therapeutics secured $270 million that will be used to advance its fully integrated gene therapy pipeline and expand engineering, manufacturing and computation.
-
Innovation community at The Oxford Science Park expands further as companies move into the Hayakawa Building
5/16/2022
The innovation community at The Oxford Science Park, one of Europe's leading locations for science and technology companies, continues to expand as firms move into the newly refurbished Hayakawa Building.
-
Inventprise Inaugurates Manufacturing Facility for High-Capacity Supply of Pneumococcal Conjugate Vaccines
5/10/2022
Inventprise, a biotechnology company specializing in novel, affordable and impactful vaccines, announced the inauguration of its new manufacturing facility for high-capacity supply of a 25-valent Pneumococcal Conjugate Vaccine for low- and middle-income countries.
-
Waters and University of Delaware Announce Official Opening of Immerse Delaware Lab
5/5/2022
Waters Corporation and The University of Delaware announced the grand opening of Immerse™ Delaware, a new Waters innovation and research laboratory.
-
Avance Biosciences Announces Validation of New Facilities, Expansion of Mammalian Cell Culture and Protein Analysis Services
5/5/2022
Avance Biosciences announced completion of move-in and validation of an additional 26,000 square feet of laboratory space acquired in the past year.
-
Over the past several years, The Lone Star State has been growing in significance as a life sciences hub. Now the industry is flocking to Hays County and its Innovation Corridor.
-
SHL Healthcare AB establishes new manufacturing facility in Europe
4/29/2022
SHL Healthcare AB, a leading manufacturer for patient slings, alternating pressure mattresses & medical soft goods, has just announced the establishment of its first production facility factory in Europe.
-
BeiGene Breaks Ground on New Manufacturing and Clinical R&D Center at the Princeton West Innovation Campus in New Jersey
4/29/2022
BeiGene, Ltd. announced the groundbreaking of its flagship U.S. manufacturing and clinical R&D center at the Princeton West Innovation Campus in Hopewell, N.J.
-
Hospital for Special Surgery (HSS) Opens Major Expansion on Long Island
4/25/2022
Hospital for Special Surgery, the world's top-ranked health system specialized in orthopedic care, marked a major expansion and renovation of its Uniondale location with a ribbon-cutting ceremony last week.
-
The company brings to the arena bioengineered tissues that repair, restore or replace an organ or tissue functioning, called Tissue Therapeutics.
-
Seagen, Inc. and NovoCure Ltd. have each announced plans to open new facilities in the coming years, expanding local employment opportunities and respective presences in the biotech industry.
-
Thermo Fisher Scientific Opens Bioprocessing Manufacturing Site in Ogden, Utah
4/20/2022
Thermo Fisher Scientific celebrated the opening of its new single-use technology manufacturing site in Ogden, Utah.
-
The new building will suit multiple life sciences industry segments, including biopharma, medtech, agroscience and more.
-
The new facility is expected to bolster innovation across all facets of manufacturing to allow the company to fully develop and commercialize cancer treatments for patients in need.
-
Australia’s Chimeric Therapeutics has partnered with WuXi ATU on two autologous CAR T-cell therapies for solid tumors. Switzerland-based CDR-Life closed a $76 million Series A.